AAL

Analyst Sees Huge Upside For Arcadia Biosciences Stock

RDKA has been prone to making big moves this year

Jun 19, 2018 at 9:32 AM
facebook X logo linkedin


Agricultural biotech Arcadia Biosciences Inc (NASDAQ:RKDA) is again making a big move on the charts, after receiving its first analyst recommendation since going public roughly three years ago. H.C. Wainwright initiated coverage on RKDA stock with a "buy" rating and a stunning $20 price target, meaning it expects the shares to more than double, as they closed Monday at $8.16. The analyst in coverage suggested there are a number of potential catalysts that could boost RKDA, including the company's wheat program.

While the $20 price target certainly seems ambitious, it's far from uncharted territory for the security. In fact, Arcadia traded as high as $66.56 back in March, following the positive results for its wheat program. Since then it's struggled to gain upside momentum, however, hitting a near-term low of $7.31 about a month ago. In today's trading, RKDA shares are up 5.4% at $8.60.

But despite the stock's depressed price -- its 14-day Relative Strength Index (RSI) was 33 at yesterday's close -- many traders continue to bet against it. That's based on a dramatic 278.4% surge in short interest during the last two reporting periods. In fact, short interest on Arcadia Biosciences stock is at an all-time high.

 

Same-Day Trading Power: +227% YTD and Counting  — Get in for $10!

We're celebrating 44 years of helping traders win, and you can now tap into one of our most explosive services — Dynamite Day Trading Signals — for just $10.

This service was built for one thing: capturing intraday gains with precision. 

Access two highly-vetted options trades each week -  Complete with defined entries, exits, and a clear plan for same-day profits.

👉 Click Here to Learn More and Position Yourself to Take Action When the Next Alert Hits.